Entropy Technologies’s Pediatrix Medical MD Stock Holding History

Entropy Technologies’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-17,022	Closed	-$158K	–	813
2023 Q4	$158K	Buy	+17,022	New	+$176K	0.03%	526

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Entropy Technologies's MD Position: Q1 2024 in Review

Entropy Technologies sold out of Pediatrix Medical (MD) in Q1 2024, closing a stake of 17,022 shares — an estimated $158K sold.

Entropy Technologies first reported a position in MD in Q4 2023 and held it in 1 quarter. The position peaked at $158K in Q4 2023. 213 funds tracked by Wall St. Rank hold MD as of Q1 2024.

Entropy Technologies reported no remaining Pediatrix Medical position as of Q1 2024 after selling out during the quarter.
Entropy Technologies sold 17,022 Pediatrix Medical shares in Q1 2024, an estimated $158K.
Entropy Technologies first reported a position in Pediatrix Medical in Q4 2023 and held it in 1 quarter.
Entropy Technologies's Pediatrix Medical position peaked at $158K in Q4 2023.
213 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2024.

Based on Entropy Technologies's 13F filing for Q1 2024, filed 8 May 2024.